This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pearson Murphy, B. E. Articles by Allison, C. M. Search for Related Content PubMed PubMed Citation Articles by Pearson Murphy, B. E. Articles by Allison, C. M.

Neuroactive Ring A-Reduced Metabolites of Progesterone in Human Plasma during Pregnancy: Elevated Levels of 5-Dihydroprogesterone in Depressed Patients during the Latter Half of Pregnancy

Psychoendocrinology Unit, Allan Memorial Institute (B.E.P.M., F.-Y.H., C.M.A.), Departments of Psychiatry (B.E.P.M., S.I.S., C.M.A.), Obstetrics & Gynecology (B.E.P.M.), and Medicine (B.E.P.M.), McGill University, Montréal, Québec, Canada H3G 1A4

Address all correspondence and requests for reprints to: Beverley E. Pearson Murphy, M.D., Ph.D., Psychoendocrinology Unit, 1033 Pine Avenue, West Montréal, Québec, Canada H3A 1A1. E-mail: bev. murphy{at}mcgill.ca

Abstract

Progesterone and its 5 reduced metabolite, 5-dihydroprogesterone, rise greatly in pregnancy. Both are known to have anesthetic properties, as do a number of other ring A-reduced progesterone metabolites. The possible significance of these steroids with respect to the mood changes that are common in pregnancy and in the puerperium has not been explored. In this study, pregnenolone, progesterone, and five neuroactive progesterone metabolites: the 5 and 5ß dihydroprogesterones (DHP), and three tetrahydroprogesterones (THP)—3,5-THP, 3ß,5ß-THP, and 3ß,5-THP—were studied at various stages of pregnancy and in the early postpartum period.

Levels of all of the steroids rose greatly during pregnancy (P < 0.001), being highest for progesterone (562-fold the follicular level), 5-DHP (161-fold), 3ß,5-THP (56-fold), 3,5-THP (37-fold), pregnenolone (30-fold), 5ß–DHP (16-fold) and 3ß,5ß-THP (16-fold) at 37 wk of gestation. During the period 2–7 d postpartum, the level of progesterone fell precipitously, whereas those of pregnenolone and the metabolites fell more slowly and mean levels were still elevated compared with follicular levels 2 wk after delivery. By 7 wk postpartum, only 3,5-tetrahydroprogesterone and 3ß,5ß-tetrahydroprogesterone remained slightly elevated (P 0.012 and 0.007, respectively).

Mean levels of the progesterone metabolites tended to be higher in depressed patients compared with controls, and this difference reached significance for 5-dihydroprogesterone both at 27 wk (P = 0.04) and at 37 wk (P = 0.02) of gestation (combined, P = 0.003).

These results show that all five of these metabolites rise markedly during pregnancy and suggest that alterations in progesterone metabolites may be involved in the mood changes of pregnancy and the puerperium.

This article has been cited by other articles:

				R. Kancheva, M. Hill, D. Cibula, H. Vcelakova, L. Kancheva, J. Vrbikova, T. Fait, A. Parizek, and L. Starka Relationships of circulating pregnanolone isomers and their polar conjugates to the status of sex, menstrual cycle, and pregnancy J. Endocrinol., October 1, 2007; 195(1): 67 - 78. [Abstract] [Full Text] [PDF]

				K. A. Hagedorn, C.-L. Cooke, J. R. Falck, B. F. Mitchell, and S. T. Davidge Regulation of Vascular Tone During Pregnancy: A Novel Role for the Pregnane X Receptor Hypertension, February 1, 2007; 49(2): 328 - 333. [Abstract] [Full Text] [PDF]

				P. M. Sheehan, G. E. Rice, E. K. Moses, and S. P. Brennecke 5{beta}-Dihydroprogesterone and steroid 5{beta}-reductase decrease in association with human parturition at term Mol. Hum. Reprod., July 1, 2005; 11(7): 495 - 501. [Abstract] [Full Text] [PDF]

				A. Parizek, M. Hill, R. Kancheva, H. Havlikova, L. Kancheva, J. Cindr, A. Paskova, V. Pouzar, I. Cerny, P. Drbohlav, et al. Neuroactive Pregnanolone Isomers during Pregnancy J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 395 - 403. [Abstract] [Full Text] [PDF]